One thing that may speed up the (20 patient trial)
Is the fact that (16 Hospitals/Centres) are taking part in the trials
Therefore there will be only (1 to 2 patients) trialled per (Hospital/Centre)
Cash is also looking good still with $9,443,000 left, &
Forecast outflows for this quarter of $2,300,000
Plus can expect further government R&D tax rebates to be forthcoming
OSL Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)